SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

HeartMate 3 LVAD

With Full Maglev Flow Technology

Stages of Heart Failure

Recognizing the Stages of Heart Failure

Stages of heart failure1

Bar chart showing steps within the four stages of heart failure with recommendations on heart failure therapies based on stages.

The New York Heart Association (NYHA) classifies the stages of heart failure as follows:2

No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).

Class 1 with silhouette of man running

Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).

Class 2 with silhouette of man walking.

Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation or dyspnea.

Class 3 with silhouette of weak man walking slowly.

Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.

Class IV with silhouette of man sitting in chair.

The American College of Cardiology/American Heart Association categorize the development and progression of heart failure into 4 stages: A through D.1,3

Stage A

Patients at high risk of developing heart failure who are asymptomatic and have no identified structural or functional cardiac abnormalities.

Stage B

Patients with structural heart disease associated with the development of heart failure but who are asymptomatic.

Stage C

Patients who have current or prior symptoms of heart failure associated with underlying structural disease.

Stage D

Patients with advanced structural heart disease and marked symptoms of heart failure at rest despite optimal medical management and who require specialized interventions.

Common symptoms of the advanced heart failure patient4

  • Dyspnea
  • Right ventricular failure
  • Fatigue
  • Edema
  • Abdominal distention
  • Sleep disturbances
  • Intolerance to previously tolerated doses of ACE inhibitors and beta blockers
  • Escalating diuretics with persistent congestion
Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

This device is commercially available for use in select international markets.

References

  1. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007-2018.
  2. https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure. Accessed on Dec. 10, 2020.
  3. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 2001;104:2996-3007.
  4. AbouEzzeddine OF, Redfield MM. Who has advanced heart failure? Definition and epidemiology. Congest Heart Fail. 2011;17:1-18.

MAT-2105170 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0